Author

Giorgio Treglia

a) Ente Ospedaliero Cantonale b) Universit

Biography

Dr. Giorgio Treglia is currently a research scientist and nuclear medicine physician at the Oncology Institute of Southern Switzerland in Bellinzona and Lugano (Switzerland). He obtained his M.D. degree in 2003 and his post-graduate degree in nuclear medicine in 2007 from the Catholic University of Rome (Italy). Previous work experience: nuclear medicine physician at the Major Hospital of Bologna (Italy) from 2008 to 2009 and nuclear medicine physician at the Gemelli University Hospital of Rome (Italy) from 2010 to 2012.
Title
Cited by
Year
Perioperative costs of local or regional anesthesia versus general anesthesia in the outpatient setting: a systematic review of recent literature
V Graff, L Gabutti, G Treglia, M Pascale, L Anselmi, S Cafarotti, DL Regina, ...Brazilian Journal of Anesthesiology 3, 316-339, 2023202
7
2023
Prognostic value of texture analysis of the primary tumour in high‐risk neuroblastoma: An 18F‐DOPA PET study
F Fiz, G Bottoni, F Bini, F Cerroni, F Marinozzi, M Conte, G Treglia, ...Pediatric Blood & Cancer 69 (11), e29910, 2022202
5
2022
Diagnostic accuracy and added value of blood-based protein biomarkers for pancreatic cancer: A meta-analysis of aggregate and individual participant data
LNC Boyd, M Ali, MMG Leeflang, G Treglia, R de Vries, TYS Le Large, ...EClinicalMedicine , 2023202
5
2023
Potential Role of PSMA-Targeted PET in Thyroid Malignant Disease: A Systematic Review
A Rizzo, M Racca, S Dall’Armellina, RC Delgado Bolton, D Albano, ...Diagnostics 13 (3), 56, 2023202
4
2023
Trimethoprim-associated hyperkalaemia: a systematic review and meta-analysis
PB Faré, E Memoli, G Treglia, MG Bianchetti, GP Milani, P Marchisio, ...Journal of Antimicrobial Chemotherapy 77 (10), 2588-2595, 2022202
3
2022
Bone scintigraphy versus PSMA-targeted PET/CT or PET/MRI in prostate cancer: lessons learned from recent systematic reviews and meta-analyses
F Dondi, D Albano, F Bertagna, G TregliaCancers 14 (18), 4470, 2022202
3
2022
Longitudinal Body Composition Changes Detected by [18F]FDG PET/CT during and after Chemotherapy and Their Prognostic Role in Elderly Hodgkin Lymphoma
D Albano, F Dondi, G Treglia, A Tucci, M Ravanelli, D Farina, F BertagnaCancers 14 (0), 5147, 0
2
2022
Paget Disease as Common Pitfall on PET with Different Radiopharmaceuticals in Oncology: Not All That Glitters Is Gold!
F Dondi, D Albano, G Treglia, F BertagnaJournal of Clinical Medicine 11 (18), 537, 0
2
2022
A Role of [18F] FDG PET/CT for Response Assessment in Large Vessel Disease?
G Treglia, D Albano, F Dondi, F Bertagna, O GheysensSeminars in Nuclear Medicine, 0
2
2022
Can PSMA-targeting radiopharmaceuticals be useful for detecting hepatocellular carcinoma using positron emission tomography? An updated systematic review and meta-analysis
A Rizzo, M Racca, D Albano, F Dondi, F Bertagna, S Annunziata, ...Pharmaceuticals 15 (11), 1368, 0
2
2022
[18F]FDOPA positron emission tomography for cardiac innervation imaging: a new way or a dead-end street?
G Treglia, A Piccardo, V GaribottoClinical Autonomic Research 3 (6), 399-401, 0
2
2022
Comparison of the prognostic value of impaired stress myocardial blood flow, myocardial flow reserve, and myocardial flow capacity on low-dose Rubidium-82 SiPM PET/CT
Comparison of the prognostic value of impaired stress myocardial blood flow, myocardial flow reserve, and myocardial flow capacity on low-dose Rubidium-8 SiPM PET/CTM Dietz, CH Kamani, G Allenbach, V Rubimbura, S Fournier, V Dunet, ...Journal of Nuclear Cardiology, 1-11, 0
2
2022
Update on Management of Medullary Thyroid Carcinoma: Focus on Nuclear Medicine
G Treglia, V Rufini, A Piccardo, A ImperialeSeminars in Nuclear Medicine, 030
2
2023
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [18F]FDG PET/CT: A Comparison between …
Role of Radiomics Features and Machine Learning for the Histological Classification of Stage I and Stage II NSCLC at [8F]FDG PET/CT: A Comparison between …F Dondi, R Gatta, D Albano, P Bellini, L Camoni, G Treglia, F BertagnaJournal of Clinical Medicine 2 (), 255, 2022202
1
2022
The Emerging Role of PET/CT with PSMA-Targeting Radiopharmaceuticals in Clear Cell Renal Cancer: An Updated Systematic Review
A Rizzo, M Racca, S Dall’Armellina, P Rescigno, GL Banna, D Albano, ...Cancers 5 (2), 355, 2023202
1
2023
Is there more than meets the eye than sentinel node localisation during lymphoscintigraphy mapping? Potential immunologic and therapeutic implications
RC Delgado Bolton, AK Calapaquí Terán, G Treglia, F GiammarileEuropean Journal of Nuclear Medicine and Molecular Imaging 50 (3), 635-637, 2023202
1
2023
Temporal Evolution and Prognostic Role of Indeterminate Response Sub-Groups in Patients with Differentiated Thyroid Cancer after Initial Therapy with Radioiodine
D Albano, P Bellini, F Dondi, A Calabrò, C Casella, S Taboni, D Lombardi, ...Cancers 5 (4), 270, 2023202
1
2023
Diagnostic tests for medullary thyroid carcinoma: an umbrella review
P Trimboli, C Mian, A Piccardo, G TregliaEndocrine, -, 2023202
1
2023
European Association of Nuclear Medicine (EANM) Focus 4 consensus recommendations: molecular imaging and therapy in haematological tumours
C Nanni, C Kobe, B Baeßler, C Baues, R Boellaard, P Borchmann, A Buck, ...The Lancet Haematology 0 (5), e367-e38, 2023202
1
2023
FAPI PET/CT in infectious, inflammatory, and rheumatological diseases:“watch it like a hawk” or “one swallow does not make a summer”?
G Treglia, D AlbanoEuropean Journal of Nuclear Medicine and Molecular Imaging 50 (7), 848-850, 2023202
1
2023

Referred From: https://scholar.google.com/citations?user=FosYqoEAAAAJ&hl=en&oi=ao

Cited by
Citations 11148
h-index 61
i10-index 234
Recommended Journals
Open Access Journals